Phosphodiesterase inhibitors to repair brain and/or retinal injury in human newborns
OwnerPia Wintermarkinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure concerns the use of a phosphodiesterase inhibitor, such as, for example, sildenafil, to repair a brain and/or a retinal injury in a newborn. The phosphodiesterase inhibitor can be used in a premature or a term baby that has been exposed to hyperoxia or hypoxia which caused a brain and/or a retinal injury.
Claims17
A method for treating a brain and/or a retinal injury caused by an exposure to hyperoxia or hypoxia in a newborn having the brain and/or the retinal injury, the method comprising administering a first therapeutically effective dose of the phosphodiesterase inhibitor or a pharmaceutically acceptable salt at least 12 hours after the onset of the brain and/or the retinal injury so as to treat the brain and/or the retinal injury.
Dependencies are inferred from the claim text.